Point72 Asset Management
PASG icon

Point72 Asset Management’s Passage Bio PASG Stock Holding History

Point72 Asset Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4
Closed -$85 – 2619
2023
Q1 		$85 Buy
+4
New +$108 ﹤0.01% 2161
2021
Q3 		– Sell
-9,375
Closed -$2.48M – 1189
2021
Q2 		$2.48M Sell
9,375
-1,735
-16% -$537K 0.01% 708
2021
Q1 		$3.88M Buy
+11,110
New +$4.74M 0.02% 623

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asset Management's PASG Position: Q2 2023 in Review

Point72 Asset Management sold out of Passage Bio (PASG) in Q2 2023, closing a stake of 4 shares — an estimated $85 sold.

Point72 Asset Management first reported a position in PASG in Q1 2021 and held it in 3 quarters. The position peaked at $3.88M in Q1 2021. 54 funds tracked by Wall St. Rank hold PASG as of Q2 2023.

  • Point72 Asset Management reported no remaining Passage Bio position as of Q2 2023 after selling out during the quarter.
  • Point72 Asset Management sold 4 Passage Bio shares in Q2 2023, an estimated $85.
  • Point72 Asset Management first reported a position in Passage Bio in Q1 2021 and held it in 3 quarters.
  • Point72 Asset Management's Passage Bio position peaked at $3.88M in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Passage Bio as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.